Company Search:
Advanced Search
Sponsored Links
Apex Biotechnology Corporation Company Snapshot
Apex Biotechnology Corporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Apex Biotechnology with three other companies in this sector in Taiwan: OK Biotech Co Ltd (2017 sales of 1.23 billion Taiwanese Dollars [US$41.64 million] ), Cowealth Medical Holding Co Ltd (3.04 billion Taiwanese Dollars [US$102.55 million] of which 96% was Depar. B(Sale Reagent&Other)), and Bionime Corporation (1.82 billion Taiwanese Dollars [US$61.47 million] of which 100% was Manufacturing Medical Equipment & Medica).

Sales Analysis. During the year ended December of 2017, sales at Apex Biotechnology were 1.80 billion Taiwanese Dollars (US$60.63 million). This is a very small increase of 1.8% versus 2016, when the company's sales were 1.76 billion Taiwanese Dollars. Despite this increase, sales are still below the level achieved in 2015, when Apex Biotechnology reported sales of 1.85 billion Taiwanese Dollars.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Apex Biotechnology Corporation
  Stock Performance Chart for Apex Biotechnology Corporation
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2018): 31.20
(Figures in Taiwanese Dollars)
1 Week -1.3%   13 Weeks 2.3%  
4 Weeks -3.9%   52 Weeks -20.3%  
Apex Biotechnology Corporation Key Data:
  Ticker: 1733 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 1,795,300,000
(Year Ending Jan 2018).
Employees: 641
  Currency: Taiwanese Dollars Market Cap: 3,110,328,000
  Fiscal Yr Ends: December Shares Outstanding: 99,690,000
  Share Type: Gu Closely Held Shares: 13,237,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.